Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Octreotide is dosed at 0.01–0.04 mg/kg SC q8-12h in dogs, per Goutal CM, Brugmann BL, Ryan KA. Insulinoma in Dogs: A Review. J Am Anim Hosp Assoc. 2012;48(3):151-163. doi:10.5326/jaaha-ms-5745 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.978 (2026-08-01).. Octreotide is used in dogs for Insulinoma / gastrinoma / GI bleeding. Routes documented in dogs: SC. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Octreotide in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Sandostatin
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| SC | 0.01–0.04 mg/kg | q8-12h | Variable depending on indication; may be long-term for insulinoma | Insulinoma / gastrinoma / GI bleeding | Moderate | Goutal CM, Brugmann BL, Ryan KA. Insulinoma in Dogs: A Review. J Am Anim Hosp Assoc. 2012;48(3):151-163. — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.978 (2026-08-01). |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Long-acting somatostatin analogue that inhibits GH, insulin, glucagon, and GI peptide secretion. Reduces splanchnic blood flow and GI motility.
May cause hyperglycemia or hypoglycemia. GI side effects common. Used for insulinoma, gastrinoma, and variceal bleeding in veterinary medicine.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Octreotide dose range in dogs, with cited source references: SC 0.01–0.04 mg/kg q8-12h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Octreotide in dogs: SC.
Cited course lengths for Octreotide in dogs include: Variable depending on indication; may be long-term for insulinoma. Duration depends on the indication — match it to the specific dose rule in the table above.
Octreotide is indicated in dogs for: Insulinoma / gastrinoma / GI bleeding.
These are general warnings for Octreotide across species; consult the dog dosing table above for species-specific guidance. May cause hyperglycemia or hypoglycemia. GI side effects common. Used for insulinoma, gastrinoma, and variceal bleeding in veterinary medicine.
Why a species-specific page? Octreotide pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.